Biotech

All Articles

Biogen cans SAGE-324 partnership after crucial tremor neglect

.Biogen has conducted the final rites to its own partnership with Sage Rehabs on SAGE-324, ditching ...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout credit ratings

.On the exact same day that some Parkinson's disease drugs are actually being brought into question,...

Arch finalizes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arc Venture Partne...

Orion to utilize Aitia's 'digital twins' to locate brand new cancer drugs

.Finnish biotech Orion has actually snooped prospective in Aitia's "electronic twin" technology to e...

Windtree's shock med raises high blood pressure in newest stage 2 win

.While Windtree Therapies has actually had a hard time to expand the economic origins needed to make...

2 cancer cells biotechs combine, generating worldwide footprint

.OncoC4 is actually taking AcroImmune-- as well as its in-house professional production capabilities...

Amgen records very first stage 3 win for $400M dermatitis medication

.Amgen has shared (PDF) the initial phase 3 records on its own $400 million dermatitis medicine, con...

Biogen, UCB document phase 3 lupus succeed after stopping working earlier test

.Biogen and UCB's bet one's bottom dollar advancing into stage 3 on the back of a failed study hopes...

Aptadir hopes new RNA inhibitors can reverse tricky cancers

.Italian biotech Aptadir Therapies has actually introduced along with the pledge that its own pipeli...

Wave surfs DMD success to regulators' doors, sending stockpile

.Surge Life Sciences has actually satisfied its target in a Duchenne muscular dystrophy (DMD) resear...